ScholarWorks@SUNGKYUNKWAN UNIVERSITY

Current filters:
Current filters:
Current filters:
Current filters:
Current filters:
Add filters:

Results 1-9 of 9 (Search time: 0.336 seconds).

SCIESCOPUS
International retrospective cohort study of locoregional and systemic therapy in oligometastatic breast cancer (OLIGO-BC1).

Ueno, T[Ueno, Takayuki]; Bi, XW[Bi, XiWen]; Liu, GY[Liu, Guangyu]; Sim, SH[Sim, Sung Hoon]; Im, SA[Im, Seock-Ah]; Takao, S[Takao, Shintaro]; Wang, K[Wang, Kun]; Im, YH[Im, Young-Hyuck]; Futamura, M[Futamura, Manabu]; Ahn, SG[Ahn, Sung Gwe], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer (TNBC) with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).

Park, IH[Park, In Hae]; Kim, GM[Kim, Gun Min]; Kim, JH[Kim, Jee Hyun]; Kim, H[Kim, Hanjo]; Park, KH[Park, Kyong Hwa]; Park, YH[Park, Yeon Hee]; Baek, SK[Baek, Sun Kyung]; Sim, SH[Sim, Sung Hoon]; Ahn, HK[Ahn, Hee Kyung]; Lee, GW[Lee, Gyeong-Won], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Multicenter study for brain metastasis from breast cancer in Korea: The significance of molecular subtype (Korean Radiation Oncology Group 1612).

Kim, IA[Kim, In Ah]; Kim, JS[Kim, Jae Sik]; Kim, K[Kim, Kyubo]; Jung, W[Jung, Wonguen]; Shin, KH[Shin, Kyung Hwan]; Im, SA[Im, Seock-Ah]; Kim, HJ[Kim, Hee Jun]; Kim, YB[Kim, Yong Bae]; Chang, JS[Chang, Jee Suk]; Kim, JH[Kim, Jee Hyun], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase I dose-escalation and expansion study of JPI-547, a dual inhibitor of PARP/tankyrase in patients with advanced solid tumors.

Im, SA[Im, Seock-Ah]; Lee, S[Lee, SeungHwan]; Lee, KW[Lee, Keun Wook]; Lee, Y[Lee, Youngjoo]; Sohn, J[Sohn, Joohyuk]; Kim, JH[Kim, Jee Hyun]; Im, YH[Im, Young-Hyuck]; Park, KH[Park, Kyong Hwa]; Oh, DY[Oh, Do-Youn]; Kim, MH[Kim, Min Hwan], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Favorable prognostic factors of oligometastatic breast cancer: A subset analysis of OLIGO-BC1.

Wang, K[Wang, Kun]; Bi, XW[Bi, XiWen]; Liu, GY[Liu, Guangyu]; Ueno, T[Ueno, Takayuki]; Takao, S[Takao, Shintaro]; Sim, SH[Sim, Sung Hoon]; Im, YH[Im, Young-Hyuck]; Im, SA[Im, Seock-Ah]; Ahn, SG[Ahn, Sung Gwe]; Lee, JE[Lee, Jeong Eon], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
BEGONIA: Phase 1b/2 study of durvalumab (D) combinations in locally advanced/metastatic triple-negative breast cancer (TNBC)-Initial results from arm 1, d+paclitaxel (P), and arm 6, d+trastuzumab deruxtecan (T-DXd).

Schmid, P[Schmid, Peter]; Im, SA[Im, Seock-Ah]; Armstrong, A[Armstrong, Anne]; Park, YH[Park, Yeon Hee]; Chung, WP[Chung, Wei-Pang]; Nowecki, Z[Nowecki, Zbigniew]; Lord, S[Lord, Simon]; Wysocki, PJ[Wysocki, Piotr Jan]; Lu, YS[Lu, Yen-Shen]; Dry, H[Dry, Hannah], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.15PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Survival outcomes of young patients under 40 with breast cancer in Asian countries according to subtype: An international multicenter cohort study.

Kim, J[Kim, Jinyong]; Lee, KH[Lee, Kyung-Hun]; Park, YH[Park, Yeon Hee]; Lin, CH[Lin, Ching-Hung]; Lu, YS[Lu, Yen-Shen]; Ueno, T[Ueno, Takayuki]; Yap, YS[Yap, Yoon Sim]; Yeo, W[Yeo, Winnie]; Liu, Q[Liu, Qiang]; Leung, RCY[Leung, Roland Ching-Yu], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
An age-specific pooled analysis of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) from DESTINY-Breast01,-02, and-03

Krop, IE[Krop, Ian E.]; Wildiers, H[Wildiers, Hans]; Hurvitz, SA[Hurvitz, Sara A.]; Cortes, J[Cortes, Javier]; Im, SA[Im, Seock-Ah]; Iwata, H[Iwata, Hiroji]; Andre, F[Andre, Fabrice]; Saura, C[Saura, Cristina]; Modi, S[Modi, Shanu]; Kim, SB[Kim, Sung-Bae], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase IB/II study of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer (KCSG BR18-16).

Kim, SH[Kim, Se Hyun]; Suh, KJ[Suh, Koung Jin]; Im, SA[Im, Seock-Ah]; Lee, KH[Lee, Kyung-Hun]; Kim, MH[Kim, Min Hwan]; Sohn, J[Sohn, Joohyuk]; Park, YH[Park, Yeon Hee]; Kim, JY[Kim, Ji-Yeon]; Jeong, JH[Jeong, Jae Ho]; Lee, KE[Lee, Kyoung Eun], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
1

Discover

Date Issued

Language

Journal Index

STATISTICS
Total View :5,506,925
Today View :3,584

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어